LABCORP HOLDINGS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value
LABCORP HOLDINGS INC. (LH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value of $30.39 per share for the 3-month period ending 2019-12-31, per its 10-K filed 2020-02-28.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue · last filed 2020-02-28
- LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for the quarter ending 2019-12-31 was $30.39.
- LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for the quarter ending 2019-03-31 was $34.40.
- LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2019 was $39.85, a 10.19% decline from fiscal 2018.
- LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2018 was $44.37, a 35.48% increase from fiscal 2017.
- LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2017 was $32.75.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|
| 2019-12-31 | $30.39 10-K · filed 2020-02-28 | $39.85 10-K · filed 2020-02-28 |
| 2019-03-31 | $34.40 10-K · filed 2020-02-28 | |
| 2018-12-31 | $44.37 10-K · filed 2020-02-28 | |
| 2017-12-31 | $32.75 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |